Endoscopic enucleation for prostate larger than 60 mL: comparison between holmium laser enucleation and plasmakinetic enucleation.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 13 04 2020
accepted: 22 07 2020
pubmed: 29 7 2020
medline: 9 10 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

To compare perioperative and functional outcomes of two different energy sources, holmium laser and bipolar current for endoscopic enucleation of prostate larger than 60 mL. A prospective, monocentric, comparative, non-randomized study was conducted including all patients treated for prostate larger than 60 mL, measured by transrectal ultrasound. Patients were assigned to each group based on the surgeons' practice. Perioperative data were collected (preoperative characteristics, operating, catheterization and hospitalization times, hemoglobin loss, complications) and functional outcomes (IPSS, IPSS Quality of Life (QoL), PSA) at 3 months and 1 year. 100 patients were included in each group from October 2015 to March 2018. No differences between HoLEP and plasma groups were observed at baseline, except for mean IPSS score, IPSS QoL score and preoperative PVR that were significantly higher in the HoLEP group. Operating time (142.1 vs 122.4 min; p = 0.01), catheterization time (59.6 vs 44.4 h; p = 0.01) and hospitalization time (2.5 vs 1.8 days; p = 0.02) were significantly shorter in the plasma group. Complication and transfusion rate were no significantly different between HoLEP and plasma. No significant differences were observed concerning functional outcomes at 3 months and 1 year. The urinary incontinence rate was higher 21.1% vs 6.4% (p < 0.01) at 3 months in HoLEP group, but no difference was observed at 1 year. Holmium and plasma are both safe and effective for endoscopic treatment for prostate larger than 60 mL. Operating, catheterization and hospitalization times were significantly shorter in the plasma group. The complication rate and functional outcomes were not significantly different.

Identifiants

pubmed: 32719929
doi: 10.1007/s00345-020-03382-x
pii: 10.1007/s00345-020-03382-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2011-2018

Références

Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C et al (2015) EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol 67:1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038
doi: 10.1016/j.eururo.2014.12.038 pubmed: 25613154
Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9:151–153. https://doi.org/10.1089/end.1995.9.151
doi: 10.1089/end.1995.9.151 pubmed: 7633476
Tan AHH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170:1270–1274. https://doi.org/10.1097/01.ju.0000086948.55973.00
doi: 10.1097/01.ju.0000086948.55973.00 pubmed: 14501739
Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94:1201–1208. https://doi.org/10.1002/bjs.5916
doi: 10.1002/bjs.5916 pubmed: 17729384
Yin L, Teng J, Huang C-J, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27:604–611. https://doi.org/10.1089/end.2012.0505
doi: 10.1089/end.2012.0505 pubmed: 23167266
Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, De La Rosette J (2011) Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int 107:1030–1043. https://doi.org/10.1111/j.1464-410X.2010.09954.x
doi: 10.1111/j.1464-410X.2010.09954.x pubmed: 21438974
Herrmann TRW, Liatsikos EN, Nagele U, Traxer O, Merseburger AS (2012) EAU Guidelines Panel on Lasers, Technologies. EAU guidelines on laser technologies. Eur Urol 61:783–95. https://doi.org/10.1016/j.eururo.2012.01.010
doi: 10.1016/j.eururo.2012.01.010 pubmed: 22285403
El Tayeb MM, Jacob JM, Bhojani N, Bammerlin E, Lingeman JE (2016) Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation. J Endourol 30:805–809. https://doi.org/10.1089/end.2016.0070
doi: 10.1089/end.2016.0070 pubmed: 27065437
Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert R (2015) Evaluation of the Learning Curve for Holmium Laser Enucleation of the Prostate Using Multiple Outcome Measures. Urology 86:824–829. https://doi.org/10.1016/j.urology.2015.07.021
doi: 10.1016/j.urology.2015.07.021 pubmed: 26254171
Robert G, Cornu J-N, Fourmarier M, Saussine C, Descazeaud A, Azzouzi A-R et al (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117:495–499. https://doi.org/10.1111/bju.13124
doi: 10.1111/bju.13124 pubmed: 25781490
Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177:1468–1474. https://doi.org/10.1016/j.juro.2006.11.091
doi: 10.1016/j.juro.2006.11.091 pubmed: 17382757
Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 170:1847–1850. https://doi.org/10.1097/01.ju.0000092035.16351.9d
doi: 10.1097/01.ju.0000092035.16351.9d pubmed: 14532790
Zhao Z, Zeng G, Zhong W, Mai Z, Zeng S, Tao X (2010) A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol 58:752–758. https://doi.org/10.1016/j.eururo.2010.08.026
doi: 10.1016/j.eururo.2010.08.026 pubmed: 20800340
Hirasawa Y, Ide H, Yasumizu Y, Hoshino K, Ito Y, Masuda T (2012) Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasia. BJU Int 110:E864–869. https://doi.org/10.1111/j.1464-410X.2012.11381.x
doi: 10.1111/j.1464-410X.2012.11381.x pubmed: 22938513
Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W et al (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 189:1427–1431. https://doi.org/10.1016/j.juro.2012.10.117
doi: 10.1016/j.juro.2012.10.117 pubmed: 23123549
Luo Y-H, Shen J-H, Guan R-Y, Li H, Wang J (2014) Plasmakinetic enucleation of the prostate vs plasmakinetic resection of the prostate for benign prostatic hyperplasia: comparison of outcomes according to prostate size in 310 patients. Urology 84:904–910. https://doi.org/10.1016/j.urology.2014.06.025
doi: 10.1016/j.urology.2014.06.025 pubmed: 25150180
Neill MG, Gilling PJ, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR et al (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68:1020–1024. https://doi.org/10.1016/j.urology.2006.06.021
doi: 10.1016/j.urology.2006.06.021 pubmed: 17095078
Habib E, Ayman LM, ElSheemy MS, El-Feel AS, Elkhouly A, Nour HH et al (2020) Holmium Laser Enucleation vs Bipolar Plasmakinetic Enucleation of a Large Volume Benign Prostatic Hyperplasia: A Randomized Controlled Trial. J Endourol 34:330–338. https://doi.org/10.1089/end.2019.0707
doi: 10.1089/end.2019.0707 pubmed: 31813283
Giulianelli R, Gentile B, Albanesi L, Tariciotti P, Mirabile G (2015) Bipolar Button Transurethral Enucleation of Prostate in Benign Prostate Hypertrophy Treatment: A New Surgical Technique. Urology 86:407–413. https://doi.org/10.1016/j.urology.2015.03.045
doi: 10.1016/j.urology.2015.03.045 pubmed: 26189138
Scoffone CM, Cracco CM (2016) The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique. World J Urol 34:1175–1181. https://doi.org/10.1007/s00345-015-1741-y
doi: 10.1007/s00345-015-1741-y pubmed: 26658753
Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M et al (2008) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 179:S87–90. https://doi.org/10.1016/j.juro.2008.03.143
doi: 10.1016/j.juro.2008.03.143 pubmed: 18405765
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–166. https://doi.org/10.1016/j.eururo.2007.08.036
doi: 10.1016/j.eururo.2007.08.036 pubmed: 17869409
Hirasawa Y, Kato Y, Fujita K (2017) Transurethral Enucleation with Bipolar for Benign Prostatic Hyperplasia: 2-Year Outcomes and the Learning Curve of a Single Surgeon’s Experience of 603 Consecutive Patients. J Endourol 31:679–685. https://doi.org/10.1089/end.2017.0092
doi: 10.1089/end.2017.0092 pubmed: 28462670
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568. https://doi.org/10.1016/j.eururo.2006.04.003
doi: 10.1016/j.eururo.2006.04.003 pubmed: 16713070
Nam JK, Kim HW, Lee DH, Han J-Y, Lee JZ, Park S-W (2015) Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate. World J Mens Health 33:88–94. https://doi.org/10.5534/wjmh.2015.33.2.88
doi: 10.5534/wjmh.2015.33.2.88 pubmed: 26331125 pmcid: 4550601
Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F et al (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55:1345–1357. https://doi.org/10.1016/j.eururo.2009.03.070
doi: 10.1016/j.eururo.2009.03.070 pubmed: 19361906
Elmansy HM, Kotb A, Elhilali MM (2011) Is there a way to predict stress urinary incontinence after holmium laser enucleation of the prostate? J Urol 186:1977–1981. https://doi.org/10.1016/j.juro.2011.06.063
doi: 10.1016/j.juro.2011.06.063 pubmed: 21944135
Xiong W, Sun M, Ran Q, Chen F, Du Y, Dou K (2013) Learning curve for bipolar transurethral enucleation and resection of the prostate in saline for symptomatic benign prostatic hyperplasia: experience in the first 100 consecutive patients. Urol Int 90:68–74. https://doi.org/10.1159/000343235
doi: 10.1159/000343235 pubmed: 23147029
Vavassori I, Hurle R, Vismara A, Manzetti A, Valenti S (2004) Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol 18:109–112. https://doi.org/10.1089/089277904322836767
doi: 10.1089/089277904322836767 pubmed: 15006063
Geavlete B, Stanescu F, Iacoboaie C, Geavlete P (2013) Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison. BJU Int 111:793–803. https://doi.org/10.1111/j.1464-410X.2012.11730.x
doi: 10.1111/j.1464-410X.2012.11730.x pubmed: 23469933
Peng B, Huang J, Wang G, Zhang H, Liu M (2016) Transurethral enucleation of prostate with button electrode plasmakinetic vaporization for the treatment of Benign Prostatic Hyperplasia. Sci Rep. https://doi.org/10.1038/srep39583
doi: 10.1038/srep39583 pubmed: 28008957 pmcid: 5180227
Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL et al (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19:550–554. https://doi.org/10.1089/end.2005.19.550
doi: 10.1089/end.2005.19.550 pubmed: 15989443
Aus G, Bergdahl S, Frösing R, Lodding P, Pileblad E, Hugosson J (1996) Reference range of prostate-specific antigen after transurethral resection of the prostate. Urology 47:529–531. https://doi.org/10.1016/S0090-4295(99)80489-0
doi: 10.1016/S0090-4295(99)80489-0 pubmed: 8638362
Herrmann TRW (2016) Enucleation is enucleation is enucleation is enucleation. World J Urol 34:1353–1355. https://doi.org/10.1007/s00345-016-1922-3
doi: 10.1007/s00345-016-1922-3 pubmed: 27585786

Auteurs

P- M Patard (PM)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France. pm.patard@gmail.com.

M Roumiguie (M)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

S Sanson (S)

Department of Urology, Clinique du Pont de Chaume, 330 Avenue Marcel Unal, Montauban, France.

J- B Beauval (JB)

Department of Urology, Saint Jean Languedoc/La Croix du Sud Hospital, Toulouse, France.

E Huyghe (E)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

M Soulié (M)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

B Malavaud (B)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

X Gamé (X)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

P Rischmann (P)

Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 1 Avenue J Poulhès, 31059, Toulouse Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH